Literature DB >> 1408232

Soft tissue effects of the THC:YAG laser on canine vocal cords.

S L Kay1, M C Oz, M Haber, A Blitzer, M R Treat, S L Trokel.   

Abstract

Recently, a laser based on a thulium-holmium-chromium (THC) doped Yttrium-aluminum-garnet (YAG) rod has been developed that produces light of 2.15 microns wavelength and can be transmitted through a low OH- silica fiberoptic cable. This wavelength falls on one of the peaks of the energy absorption spectrum of water. Thus, the THC:YAG laser eliminates the disadvantage of a cumbersome delivery system found in the CO2 laser while still providing precise cutting and minimal tissue injury inherent in lasers emitting light absorbed by water. We evaluated the soft tissue effects of this laser on canine vocal cords. Ablative lesions were produced by the THC:YAG laser and histologically examined on postoperative days 1, 7, and 28. Results indicate that the depth of tissue penetration is easily controlled and the healing response to tissue injury is comparable to that of the CO2 laser. The THC:YAG laser should prove to be a superior laser for use in otorhinolaryngology, especially when adapted to a flexible endoscope.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1408232     DOI: 10.1177/019459989210700317

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1.  Histopathological and postoperative behavioral comparison of rodent oral tongue resection: fiber-enabled CO2 laser versus electrocautery.

Authors:  Courtney B Shires; Jennifer M Saputra; Lauren King; Jerome W Thompson; Detlef H Heck; Merry E Sebelik; John D Boughter
Journal:  Otolaryngol Head Neck Surg       Date:  2012-04-24       Impact factor: 3.497

2.  A rabbit vocal fold laser scarring model for testing lamina propria tissue-engineering therapies.

Authors:  Ted Mau; Mindy Du; Chet C Xu
Journal:  Laryngoscope       Date:  2014-06-03       Impact factor: 3.325

Review 3.  Lasers in clinical urology: state of the art and new horizons.

Authors:  Andrew J Marks; Joel M H Teichman
Journal:  World J Urol       Date:  2007-03-28       Impact factor: 3.661

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.